Cohere Health is a healthcare technology company that leverages AI and machine learning to transform the prior authorization process from a transaction to a care journey management, aiming to improve care access and quality outcomes.

Duncan Reece

Siva Namasivayam

Cohere Health

CarelonRx is a pharmacy benefit manager that provides clinical insights and solutions for managing prescriptions and improving health outcomes.

CarelonRx

Cohere Health is a clinical intelligence company that provides intelligent prior authorization as a springboard to better quality outcomes by aligning physicians and health plans on evidence-based care paths for the patient's entire care journey. Cohere's intelligent prior authorization solutions reduce administrative expenses while improving patient outcomes. The company is a winner of the TripleTree iAward and has been named to both Fierce Healthcare's Fierce 15 and CB Insights' Digital Health 150 lists. Cohere's investors include Flare Capital Partners, Define Ventures, Deerfield, Polaris Partners, and Longitude Capital.

Humana

Define Ventures

Flare Capital Partners

Polaris Partners

Longitude Capital

Deerfield

Deerfield Management

🚨 The Centers for Medicare & Medicaid Services has passed the long-awaited Interoperability and Prior Authorization Final Rule (CMS-0057-F).

Cohere Health and the American Academy of Orthopaedic Surgeons (AAOS) joined forces to emphasize how intelligent prior authorization can help health plans achieve both CMS compliance and better patient outcomes.

With deadlines quickly approaching, health plans should already be assessing and implementing solutions for the new rule’s requirements. Given the time and resources needed to achieve compliance, it’s imperative to start preparing now.

Download the white paper to learn more and get ahead of the deadlines. ⏳

At Cohere Health, we're proud to recognize Black History Month and celebrate our employees.

Cherokee Coleman, Intake Specialist, shared her thoughts on #BlackHistoryMonth and the importance of getting to celebrate at work:

"It creates a sense of pride, promotes understanding, and encourages conversations about equality." ♥

Health plans: Learn how to navigate the path to smarter #priorauthorization with Dr. Mary Krebs, Cohere Health's Medical Director of Primary Care. 📍

🟢 Dr. Krebs dives deeper into green lighting (a more efficient alternative to gold carding) and its positive impact on physicians in Medical Economics.

Our CEO, Siva Namasivayam, recently sat down with Jenée Rideaux for an episode of The Pulse Podcast by Wharton Digital Health. 🎙

They talked about Siva's entrepreneurship journey, the responsible use of AI in healthcare, and how Cohere Health is transforming #priorauthorization from an administrative burden into a driver of care quality improvement. 💡

Tune into the conversation here 👉 https://lnkd.in/d-6z4vD5

“Emphasizing teamwork, empathy, and open dialogue, we turn challenges into opportunities, creating a supportive and resilient work environment." 🤝

In a recent Built In Boston article, Felix Adenodi, Lead Software Engineer at Cohere Health, discusses how our spirit of collaboration makes for a great working environment.

💡 "[Our] culture not only solves immediate problems but also builds lasting relationships and a strong, adaptable team."

Read more, then check out roles we're #hiring for now 👉 https://lnkd.in/ey7Pe6Sn

Metric
Company Name	Cohere Health	CarelonRx
Symbol
MSH ID	COM:COHEREHEALTH	COM:CARELONRX
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare Technology	Pharmacy Benefit Management
Country	US	US
Stage	Series C
Employee Count	586
Website	coherehealth.com	carelonrx.com
LinkedIn	coherehealth	carelonrx
Founders

Metric
Market Cap	162.58M
Enterprise Value
Monthly Web Traffic	238.85K
Web Traffic Growth	0.10
Valuation
Raised Capital	50M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:COHEREHEALTH

Cohere Health

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue